What You Need To Know Ahead of Pfizer's Earnings on Tuesday

Analyst Estimates for Q4 2023Q3 2023Q4 2022Revenue$14.3 billion$13.2 billion$24.3 billionAdjusted Earnings (or Loss) Per Share(19 cents)(17 cents)$1.14Adjusted Net Income (or Loss)($1.1 billion)($968 million)$6.55 billion Key Metric After Pfizer has struggled amid poor demand for its COVID-19 products, including its Paxlovid treatment and the Comirnaty vaccine, investors will want to watch for the company’s reported revenue from this segment. Analysts are projecting sales of the vaccine to fall 52% in th ...